1. Home
  2. PLBY vs PROF Comparison

PLBY vs PROF Comparison

Compare PLBY & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLBY

PLBY Group Inc.

HOLD

Current Price

$1.30

Market Cap

204.4M

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.66

Market Cap

243.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBY
PROF
Founded
1953
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.4M
243.2M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
PLBY
PROF
Price
$1.30
$6.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$12.00
AVG Volume (30 Days)
1.1M
63.5K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
25.89
EPS
N/A
0.19
Revenue
$120,928,000.00
$16,098,000.00
Revenue This Year
$9.17
$92.40
Revenue Next Year
$7.10
$64.10
P/E Ratio
N/A
$35.74
Revenue Growth
4.13
50.73
52 Week Low
$1.19
$3.92
52 Week High
$2.75
$8.95

Technical Indicators

Market Signals
Indicator
PLBY
PROF
Relative Strength Index (RSI) 37.11 46.15
Support Level $1.22 $6.54
Resistance Level $1.94 $7.07
Average True Range (ATR) 0.08 0.29
MACD 0.01 -0.05
Stochastic Oscillator 33.90 35.67

Price Performance

Historical Comparison
PLBY
PROF

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: